CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Plaks V, Rossi JM, Chou J, Wang L, Poddar S, Han G, Wang Z, Kuang SQ, Chu F, Davis RE, Vega F, Bashir Z, Jacobson CA, Locke FL, Reagan PM, Rodig SJ, Lekakis LJ, Flinn IW, Miklos DB, Bot A, Neelapu SS.
Plaks V, et al. Among authors: kuang sq.
Blood. 2021 Sep 23;138(12):1081-1085. doi: 10.1182/blood.2021010930.
Blood. 2021.
PMID: 34041526
Free PMC article.
Clinical Trial.
No abstract available.